1. Home
  2. CORT vs JXN Comparison

CORT vs JXN Comparison

Compare CORT & JXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • JXN
  • Stock Information
  • Founded
  • CORT 1998
  • JXN 1961
  • Country
  • CORT United States
  • JXN United States
  • Employees
  • CORT N/A
  • JXN N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • JXN Life Insurance
  • Sector
  • CORT Health Care
  • JXN Finance
  • Exchange
  • CORT Nasdaq
  • JXN Nasdaq
  • Market Cap
  • CORT 7.5B
  • JXN 6.3B
  • IPO Year
  • CORT N/A
  • JXN N/A
  • Fundamental
  • Price
  • CORT $71.76
  • JXN $93.96
  • Analyst Decision
  • CORT Strong Buy
  • JXN Hold
  • Analyst Count
  • CORT 4
  • JXN 5
  • Target Price
  • CORT $138.25
  • JXN $101.20
  • AVG Volume (30 Days)
  • CORT 864.0K
  • JXN 590.5K
  • Earning Date
  • CORT 07-31-2025
  • JXN 08-05-2025
  • Dividend Yield
  • CORT N/A
  • JXN 3.41%
  • EPS Growth
  • CORT N/A
  • JXN N/A
  • EPS
  • CORT 1.11
  • JXN N/A
  • Revenue
  • CORT $716,080,000.00
  • JXN $5,704,000,000.00
  • Revenue This Year
  • CORT $35.85
  • JXN $115.58
  • Revenue Next Year
  • CORT $35.22
  • JXN $2.92
  • P/E Ratio
  • CORT $64.39
  • JXN N/A
  • Revenue Growth
  • CORT 25.71
  • JXN 29.87
  • 52 Week Low
  • CORT $33.34
  • JXN $64.70
  • 52 Week High
  • CORT $117.33
  • JXN $115.22
  • Technical
  • Relative Strength Index (RSI)
  • CORT 52.18
  • JXN 58.98
  • Support Level
  • CORT $70.75
  • JXN $88.20
  • Resistance Level
  • CORT $74.54
  • JXN $96.90
  • Average True Range (ATR)
  • CORT 2.74
  • JXN 2.87
  • MACD
  • CORT 0.26
  • JXN 0.65
  • Stochastic Oscillator
  • CORT 73.13
  • JXN 79.37

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

Share on Social Networks: